Please login to the form below

Not currently logged in
Email:
Password:

SHP625

This page shows the latest SHP625 news and features for those working in and with pharma, biotech and healthcare.

Silver lining as Shire rare disease programme hits a setback

Silver lining as Shire rare disease programme hits a setback

Shire's SHP625 (formerly known as LUM001) - a bile acid transporter inhibitor designed to correct the liver defect in ALGS - missed all its objectives in the IMAGO study involving 20 children ... SHP625 was associated with a drop of 66.1 micromoles/L in

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics